(Q27098039)

Atracurium (English)

4 October 2016

C₅₃H₇₂N₂O₁₂²⁺

1 reference

based on heuristic

inferred from SMILES

canonical SMILES

C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C

1 reference

Atracurium (English)

significant drug interaction

4 October 2016

methylprednisolone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

methylprednisolone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dexamethasone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dexamethasone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

prednisolone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

prednisolone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

prednisone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

prednisone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

triamcinolone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

triamcinolone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

betamethasone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

betamethasone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

amikacin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

amikacin

central respiratory depression

1 reference

A reference set of clinically relevant adverse drug-drug interactions

amikacin

paresis

1 reference

A reference set of clinically relevant adverse drug-drug interactions

streptomycin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

streptomycin

central respiratory depression

1 reference

A reference set of clinically relevant adverse drug-drug interactions

streptomycin

paresis

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tobramycin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tobramycin

central respiratory depression

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tobramycin

paresis

1 reference

A reference set of clinically relevant adverse drug-drug interactions

physically interacts with

Cholinergic receptor nicotinic delta subunit

1 reference

14 August 2023

Cholinergic receptor nicotinic gamma subunit

1 reference

14 August 2023

Cholinergic receptor nicotinic alpha 1 subunit

1 reference

14 August 2023

Cholinergic receptor nicotinic epsilon subunit

1 reference

14 August 2023

InChI=1S/C53H72N2O12/c1-54(22-18-38-32-48(62-7)50(64-9)34-40(38)42(54)28-36-14-16-44(58-3)46(30-36)60-5)24-20-52(56)66-26-12-11-13-27-67-53(57)21-25-55(2)23-19-39-33-49(63-8)51(65-10)35-41(39)43(55)29-37-15-17-45(59-4)47(31-37)61-6/h14-17,30-35,42-43H,11-13,18-29H2,1-10H3/q+2

Commons category

Atracurium

0 references

Identifiers

InChI

1 reference

Atracurium (English)

4 October 2016

2 references

Atracurium (English)

4 October 2016

ChEBI release 2020-09-01

2 references

atracurium (English)

4 October 2016

https://commonchemistry.cas.org/detail?cas_rn=64228-79-1

8 April 2021

1 reference

2,2'-{1,5-Pentanediylbis[oxy(3-oxo-3,1-propanediyl)]}bis[1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolinium] (English)

4 October 2016

1 reference

2,2'-{1,5-Pentanediylbis[oxy(3-oxo-3,1-propanediyl)]}bis[1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolinium] (English)

4 October 2016

1 reference

2,2'-{1,5-Pentanediylbis[oxy(3-oxo-3,1-propanediyl)]}bis[1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolinium] (English)

4 October 2016

2 references

Atracurium (English)

4 October 2016

InChIKey

Reaxys registry number

1523633

1 reference

atracurium (English)

4 October 2016

mapping relation type

2 references

atracurium (English)

4 October 2016

International Chemical Identifier

InChI

InChI=1S/C53H72N2O12/c1-54(22-18-38-32-48(62-7)50(64-9)34-40(38)42(54)28-36-14-16-44(58-3)46(30-36)60-5)24-20-52(56)66-26-12-11-13-27-67-53(57)21-25-55(2)23-19-39-33-49(63-8)51(65-10)35-41(39)43(55)29-37-15-17-45(59-4)47(31-37)61-6/h14-17,30-35,42-43H,11-13,18-29H2,1-10H3/q+2

1 reference

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

ATRACURIUM (English)

4 October 2016

1 reference

2 references

InChIKey

DSSTOX compound identifier

DTXCID7023726

0 references

Guide to Pharmacology Ligand ID

9537

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

5 February 2021

Atracurium

0 references

MeSH tree code

D03.633.100.531.085.061

0 references

RxNorm ID

1218

0 references

Human Metabolome Database ID

HMDB0014870

2 references

based on heuristic

inferred from InChIKey

InChIKey

0 references

1 reference

1 reference

atracurium (English)